Inflammatory bowel diseases (IBD) are chronic intestinal inflammations with constantly rising incidences that are associated with Western lifestyle. The two major phenotypes are Crohn’s disease and ulcerative colitis. In the present study, the influence of CCL17 on the development of experimental colitis in mice, resembling human disease, was assessed using CCL17 knockout mice. Thus, it was shown that CCL17 plays a disease promoting role, which could be demonstrated on histological, cell biological and molecular level. Taken together, this study indicates that neutralizing CCL17 might be a promising target for future treatment of IBD.
«
Inflammatory bowel diseases (IBD) are chronic intestinal inflammations with constantly rising incidences that are associated with Western lifestyle. The two major phenotypes are Crohn’s disease and ulcerative colitis. In the present study, the influence of CCL17 on the development of experimental colitis in mice, resembling human disease, was assessed using CCL17 knockout mice. Thus, it was shown that CCL17 plays a disease promoting role, which could be demonstrated on histological, cell biologi...
»